{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T06:24:37Z","timestamp":1748499877562,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-023-01573-1","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T05:01:38Z","timestamp":1684990898000},"page":"71-82","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Site-specific effects of dobutamine on cardiac conduction and refractoriness"],"prefix":"10.1007","volume":"67","author":[{"given":"Haisam","family":"Ismail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James K.","family":"Gabriels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beom Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence M.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Hentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parmanand","family":"Dasrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Seyar","family":"Rahyab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5957-4143","authenticated-orcid":false,"given":"Bruce","family":"Goldner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"issue":"2","key":"1573_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0735-1097(95)80037-H","volume":"26","author":"DP Zipes","year":"1995","unstructured":"Zipes DP, DiMarco JP, Jackman WM, et al. ACC\/AHA Task Force Report: Guidelines for Clinical Intracardiac Electrophysiological and Catheter Ablation Procedures. J Am Coll Cardiol. 1995;26(2):555\u201373.","journal-title":"J Am Coll Cardiol"},{"key":"1573_CR2","first-page":"714864","volume":"2011","author":"A D\u2019Silva","year":"2011","unstructured":"D\u2019Silva A, Wright M. Advances in imaging for atrial fibrillation ablation. Radiol Res Pract. 2011;2011:714864.","journal-title":"Radiol Res Pract"},{"issue":"6","key":"1573_CR3","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1056\/NEJMc1700244","volume":"377","author":"UN Khot","year":"2017","unstructured":"Khot UN, Vogan ED, Militello MA. Nitroprusside and Isoproterenol Use after Major Price Increases. N Engl J Med. 2017;377(6):594\u20135. https:\/\/doi.org\/10.1056\/NEJMc1700244.","journal-title":"N Engl J Med"},{"key":"1573_CR4","unstructured":"Knight BP. The rising costs of isoproterenol. EP Lab Dig. 2013;17(3)."},{"issue":"1","key":"1573_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1161\/01.RES.36.1.185","volume":"36","author":"RR Tuttle","year":"1975","unstructured":"Tuttle RR, Mills J. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res. 1975;36(1):185\u201396.","journal-title":"Circ Res"},{"issue":"7","key":"1573_CR6","first-page":"479","volume":"12","author":"DI Vanegas","year":"2006","unstructured":"Vanegas DI, Perez CDJ, Montenegro JDJ, et al. Dobutamine use for arrhythmia induction during electrical programmed heart stimulation. Rev Colomb Cardiol. 2006;12(7):479\u201383.","journal-title":"Rev Colomb Cardiol"},{"issue":"8","key":"1573_CR7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1540-8167.1997.tb00845.x","volume":"8","author":"SF Coss\u00fa","year":"1997","unstructured":"Coss\u00fa SF, Rothman SA, Chmielewski IL, Hsia HH, Vogel RL, Miller JM, Buxton AE. The effects of isoproterenol on the cardiac conduction system: site-specific dose dependence. J Cardiovasc Electrophysiol. 1997;8(8):847\u201353. https:\/\/doi.org\/10.1111\/j.1540-8167.1997.tb00845.x.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1573_CR8","doi-asserted-by":"crossref","unstructured":"Cismaru G. Arrhythmia induction in the EP lab. 1st ed. Cham, Switzerland: Springer Nature Switzerland AG;2019:71-86.","DOI":"10.1007\/978-3-319-92729-9"},{"issue":"13","key":"1573_CR9","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.jacep.2020.07.018","volume":"6","author":"C Gianni","year":"2020","unstructured":"Gianni C, Sanchez JE, Mohanty S, Trivedi C, Della Rocca DG, Al-Ahmad A, Burkhardt JD, Gallinghouse GJ, Hranitzky PM, Horton RP, Di Biase L, Natale A. High-Dose Dobutamine for Inducibility of Atrial Arrhythmias During Atrial Fibrillation Ablation. JACC Clin Electrophysiol. 2020;6(13):1701\u201310. https:\/\/doi.org\/10.1016\/j.jacep.2020.07.018.","journal-title":"JACC Clin Electrophysiol"},{"issue":"9","key":"1573_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/oxfordjournals.eurheartj.a059571","volume":"10","author":"LA Pi\u00e9rard","year":"1989","unstructured":"Pi\u00e9rard LA, Berthe C, Albert A, Carlier J, Kulbertus HE. Haemodynamic alterations during ischaemia induced by dobutamine stress testing. Eur Heart J. 1989;10(9):783\u201390. https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a059571.","journal-title":"Eur Heart J"},{"issue":"2","key":"1573_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/clc.4960240208","volume":"24","author":"D Lu","year":"2001","unstructured":"Lu D, Greenberg MD, Little R, Malik Q, Fernicola DJ, Weissman NJ. Accelerated dobutamine stress testing: safety and feasibility in patients with known or suspected coronary artery disease. Clin Cardiol. 2001;24(2):141\u20135. https:\/\/doi.org\/10.1002\/clc.4960240208.","journal-title":"Clin Cardiol"},{"issue":"6","key":"1573_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/0735-1097(92)90325-h","volume":"19","author":"PK Mazeika","year":"1992","unstructured":"Mazeika PK, Nadazdin A, Oakley CM. Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol. 1992;19(6):1203\u201311. https:\/\/doi.org\/10.1016\/0735-1097(92)90325-h.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1573_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/s0002-9149(00)01100-0","volume":"86","author":"AJ Burger","year":"2000","unstructured":"Burger AJ, Notarianni MP, Aronson D. Safety and efficacy of an accelerated dobutamine stress echocardiography protocol in the evaluation of coronary artery disease. Am J Cardiol. 2000;86(8):825\u20139. https:\/\/doi.org\/10.1016\/s0002-9149(00)01100-0.","journal-title":"Am J Cardiol"},{"issue":"4","key":"1573_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/s0022-0736(79)80004-7","volume":"12","author":"A Masoni","year":"1979","unstructured":"Masoni A, Alboni P, Malacarne C, Codeca L. Effects of dobutamine on electrophysiological properties of the specialized conduction system in man. J Electrocardiol. 1979;12(4):361\u201370. https:\/\/doi.org\/10.1016\/s0022-0736(79)80004-7.","journal-title":"J Electrocardiol"},{"issue":"4","key":"1573_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/0002-8703(75)90429-9","volume":"90","author":"C Bianchi","year":"1975","unstructured":"Bianchi C, Diaz R, Gonzales C, Beregovich J. Effecto of dobutamine on atrioventricular conduction. Am Heart J. 1975;90(4):474\u20138.","journal-title":"Am Heart J"},{"key":"1573_CR16","doi-asserted-by":"publisher","first-page":"12804","DOI":"10.1111\/anec.12804","volume":"26","author":"P Dahlberg","year":"2021","unstructured":"Dahlberg P, Diamant U, Gilljam T, Rydberg A, Bergfeldt L. QT correction using Bazett\u2019s formula remains preferable in long QT syndrome type 1 and 2. Ann Noninvasive Electrocardiol. 2021;26:12804.","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"1573_CR17","unstructured":"Northwell Health Pharmacy Department. Contracted Price for Isoproterenol and Dobutamine in 2023."}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-023-01573-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-023-01573-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-023-01573-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T07:28:43Z","timestamp":1704439723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-023-01573-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["1573"],"URL":"https:\/\/doi.org\/10.1007\/s10840-023-01573-1","relation":{},"ISSN":["1572-8595"],"issn-type":[{"type":"electronic","value":"1572-8595"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"assertion":[{"value":"18 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB #: 19\u20130934) of Northwell Health and exempted from the investigational new drug (IND) based upon a Food and Drug Administration (FDA) review. This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"this study was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"There was no outside funding for this study. The authors did not receive support from any organization for the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}